Health Trials

MSI-H Colorectal Cancer

2

Review clinical trials related to MSI-H Colorectal Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: ElephasUpdated: Jun 29, 2026Locations: 8
Eligibility criteria

Able and willing to provide informed consent for participation [+3]

Have a known auto-immune disease or prior condition (prior organ transplant, chr... [+2]

Read more
Status: Not yet recruiting

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

This study is a multi-center, single-arm, open-label phase II clinical trial, aiming to observe and evaluate the perioperative treatment of tislelizumab combined with chemotherapy (CAPOX) in stage II or III colorectal cancer with MSI-H/dMMR Patient efficacy and safety.

Participants needed: 25
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Zhengzhou UniversityUpdated: May 9, 2023
Eligibility criteria

ECOG: 0~1; [+5]

Have received anti-tumor therapy; [+8]

Read more